MBA
LAW
LANGUAGES

GENOPTIX INC. GXDX (NASDAQ)

$ 32.00

23:00

Sponsored by

Change: +0.50 (+1.59%)
Volume: 329,700

Avg. Volume:	179935
P/E Ratio:	34
EPS (Annual):	0.94
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	16,340
Institutional Shareholders:	48.24%

Last:	32.00
Change:	+0.50 (+1.59%)
Prev. Close:	31.50
Open:	29.82
Day's Range:	27.78 - 32.23
52wk Range:	20.41 - 39.79
Market Value:	520,760
Beta:

12-month EPS Change:	0.00%
Total Return Last 12 Months:	+26.23%
Total Return Last 3 Years:	+26.23%
Total Return Last 5 Years:	+26.23%
5-Year Revenue Growth Rate:	0.00%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	0.00%

Headlines on GXDX

Alert me

Sector Snap: Health care services

(NEW YORK)The winners in the final version of the Senate's Medicare reform bill should include ambulance providers, diagnostic lab operators and dialysis providers, analysts say.READ MORE

Jun 13, 2008 2:08PM

Keywords: EMS, RURL, DGX, AIQ, RDN, AMED, GTIV, MHS, LHCG, LNCR, GXDX, BRLI, DVA, LH

Clinical laboratory operators

(NEW YORK)Revenue for clinical laboratory operators should keep growing, according to an Oppenheimer & Co. analyst, and smaller companies like Bio-Reference Laboratories Inc. have a chance t...READ MORE

May 29, 2008 3:39PM

Keywords: BRLI, DGX, UNH, AET, GXDX, MTOX, BEC, GPRO, LH, CRA

Genoptix Director Sells Shares

(NEW YORK)A director of diagnostic services provider Genoptix Inc. sold 66,705 shares of common stock, according to a filing with the Securities and Exchange Commission.READ MORE

Mar 12, 2008 4:03PM

Keywords: GXDX